We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+2.44%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
AUM
$1.51B
AUM Growth
+$414M
Cap. Flow
-$406M
Cap. Flow %
-26.85%
Top 10 Hldgs %
44.89%
Holding
542
New
183
Increased
53
Reduced
33
Closed
94

Sector Composition

Rank Sector Weight
1 Miscellaneous 77.92%
2 Financials 15.61%
3 Technology 1.32%
4 Real Estate 1.26%
5 Industrials 1.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARWR icon
251
CALL
Arrowhead Research
ARWR
$12B
$408K 0.03%
+5,000
New +$369K
KOYN
252
CSLM Digital Asset Acquisition Corp III
KOYN
$323M
$406K 0.03%
40,000
VKTX icon
253
CALL
Viking Therapeutics
VKTX
$3.75B
$390K 0.03%
+10,000
New +$323K
ACAD icon
254
CALL
Acadia Pharmaceuticals
ACAD
$5.02B
$380K 0.03%
+15,000
New +$330K
EGHA
255
EGH Acquisition Corp
EGHA
$213M
$378K 0.03%
36,717
+2,716
+8% +$27.9K
NPAC
256
New Providence Acquisition Corp III
NPAC
$401M
$365K 0.02%
35,196
-184,314
-84% -$1.9M
ANNX icon
257
CALL
Annexon
ANNX
$942M
$343K 0.02%
+60,000
New +$332K
BCARW
258
DELISTED
D. Boral ARC Acquisition I Corp Warrant
BCARW
$327K 0.02%
180,709
+13,400
+8% +$19.6K
TM icon
259
Toyota
TM
$230B
$326K 0.02%
+1,934
New +$366K
FIGX
260
FIGX Capital Acquisition Corp
FIGX
$200M
$315K 0.02%
30,781
DAAQ
261
Digital Asset Acquisition Corp
DAAQ
$240M
$307K 0.02%
29,621
MDXG icon
262
MiMedx Group
MDXG
$656M
$289K 0.02%
+75,000
New +$274K
KYMR icon
263
PUT
Kymera Therapeutics
KYMR
$9.82B
$287K 0.02%
+2,500
New +$215K
INSM icon
264
Insmed
INSM
$25.9B
$267K 0.02%
+2,500
New +$303K
GSK icon
265
GSK
GSK
$102B
$262K 0.02%
+5,000
New +$264K
XRPN
266
Armada Acquisition Corp II
XRPN
$333M
$261K 0.02%
25,000
-174,130
-87% -$1.81M
ACAD icon
267
Acadia Pharmaceuticals
ACAD
$5.02B
$253K 0.02%
+10,000
New +$220K
GILD icon
268
Gilead Sciences
GILD
$181B
$253K 0.02%
+2,000
New +$264K
YUMC icon
269
Yum China
YUMC
$15.3B
$245K 0.02%
+6,000
New +$275K
CAPR icon
270
PUT
Capricor Therapeutics
CAPR
$558M
$241K 0.02%
+10,000
New +$303K
FACWW
271
Factorial Energy Inc Warrant
FACWW
$8.71M
$227K 0.02%
167,208
+67,208
+67% +$87.9K
IRON icon
272
Disc Medicine
IRON
$3.07B
$219K 0.01%
+3,000
New +$206K
SNY icon
273
Sanofi
SNY
$107B
$213K 0.01%
+5,000
New +$223K
NHICW
274
NewHold Investment Corp III Warrants
NHICW
$207K 0.01%
98,641
-45,929
-32% -$66.9K
CCIXW
275
DELISTED
Churchill Capital Corp IX Warrant
CCIXW
$204K 0.01%
261,276
+81,995
+46% +$37.3K

Similar funds

DLD Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, DLD Asset Management held 542 positions worth $1.51B, up 38% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

DLD Asset Management withdrew a net $406M in Q2 2026, closing 94 positions and reducing 33 holdings. Its most notable exit was Medline Inc, an estimated $9.79M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 78% of assets, up from 73% a quarter earlier, followed by Financials and Technology.

Against the trend, DLD Asset Management opened a new position in Amkor Technology worth $12.1M.

  • DLD Asset Management's largest Q2 2026 buy was Amkor Technology: 140,000 shares worth $12.1M.
  • DLD Asset Management added most to Norfolk Southern in Q2 2026, an estimated $4.48M increase.
  • DLD Asset Management's biggest Q2 2026 reduction was D. Boral Acquisition I Corp, cutting an estimated $4.96M.
  • DLD Asset Management fully exited Medline Inc in Q2 2026, selling an estimated $9.79M.
  • DLD Asset Management's ten largest holdings make up 45% of its $1.51B portfolio in Q2 2026.
  • DLD Asset Management opened 183 new positions and closed 94 in Q2 2026.
  • DLD Asset Management's portfolio value rose 38% quarter-over-quarter to $1.51B.

Based on DLD Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.